Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ablative Solutions closes its $9.5mm Series B round

Executive Summary

Ablative Solutions Inc. (renal denervation device to treat hypertension) closed its Series B venture round at $9.5mm. The transaction included the conversion of the 2013 bridge financing. BioStar Ventures and Michigan Accelerator Fund co-led (the latter will take a seat on the board) and were joined by founders and angel investors.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies